Erythropoietin-mediated decrease of the redox-sensitive transcription factor NF-κB is inversely correlated with the hemoglobin level

Clinical Nephrology

Volumn 58, Issue 3, 2002, Pages 179-189

  Andrassy, M ^a   Bierhaus, A ^a   Hong, M ^a   Sis, J ^a   Schiekofer, S ^a   Humpert, P M ^a   Chen, J ^a   Haap, M ^a   Renn, W ^a   Schleicher, E ^a   Haring H U ^a   Andrassy, K ^a   Nawroth, P P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Erythropoietin; Hemodialysis; NF B; Renal anemia

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FAILURE; MALE; MONONUCLEAR CELL; OXIDATION REDUCTION STATE;

EID: 0036711849     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp58179     Document Type: Article

References (45)

1. The kidney and erythropoiesis
2. NF-κB and transcriptional control of renal epithelial-inducible nitric oxide synthase
3. Improved methods for the determination of blood gluthatione
4. Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor
5. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells
6. The dietary pigment curcurmin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-κB
7. The role of oxidative stress and subsequent NF-κB activation in renal disease
8. LPS and cytokine-activated endothelium
9. Role of NF kappa B in the mortality of sepsis
10. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding
11. Lipid peroxidation and antioxidant activity in chronic haemodialysis patients treated with recombinant human erythropoietin
12. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure
13. Platelet levels of reduced glutathione, superoxide dismutase, zinc and malondialdehyde in uremic patients
14. Hypoxia induces intercellular adhesion molecule-1 on cultured human tubular cells
15. Anemia and chronic renal failure: The possible role of the oxidative state of glutathione
16. Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron
17. T cells and B cells in chronic renal failure
18. Erythropoietin
19. Erythropoietin titers in health and disease
20. Anemia of end-stage renal disease
21. Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis
22. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes
23. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative stress-sensitive transcription factor NF-kappaB
24. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure
25. Oxidative stress in haemodialysis
26. Conjugated diene fatty acids in patients with chronic renal failure. Evidence of increased lipid peroxidation?
27. Whole blood superoxide anion generation and efficiency of some erythrocyte antioxidant systems during recombinant human erythropoietin therapy of uremic anemia
28. Free oxygen species metabolism during hemodialysis with different membranes
29. Oxidation parameters in complete correction of renal anemia
30. Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rh-EPO treatment
31. Expression of influenza virus hemagglutinin activates the transcription factor NF-κB
32. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E, and iron status
33. The effect of malondialdehyde on erythrocyte deformability
34. Hematological disorders in renal failure
35. Effects of prednisolone in glomerular signal transduction cascades in experimental glomerulonephritis
36. Erythrocyte-free radical and energy metabolism
37. Formation of 4-hydroxynonenal and further aldehydic mediators of inflammation during bromotrichloromethane treatment of rat liver cells
38. Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?
39. Oxidative damage to RBC membranes and pentose phosphate shunt activity in hemodialysis patients after suspension of erythropoietin treatment
40. Increased intracellular reactive oxygen species in patients with end-stage renal failure: Effect of hemodialysis
41. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis
42. The effect of erythropoietin on the cellular defense mechanism of red blood cells in children with chronic renal failure
43. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct
44. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment
45. Reduced glutathione for the treatment of anemia during hemodialysis: A preliminary communication